theguardian.com
Peptide user tore oesophagus after using counterfeit product, Australian regulator warns
TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide
*
Follow our Australia news live blog for latest updates
*
Get our new political email, free app or daily news podcast
A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products.
The concern relates to retatrutide, a type of drug known as a peptide. Retatrutide has not been approved by the Therapeutic Goods Administration (TGA) or regulators overseas, and it can not be legally prescribed or sold in Australia. Continue reading...